Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Cephalexin for Cellulitis (HI-DOCC)
NCT05852262Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Aug 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cefalexin in cellulitis, sponsored by Ottawa Hospital Research Institute. Started Aug 2023; status: completed.
02
Drugs
cefalexin
03
Conditions
cellulitis
Beyond the preview
Go deeper on NCT05852262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05852262.